PYC Therapeutics Limited
ASX:PYC.AX
0.19 (AUD) • At close November 5, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 22.059 | 15.806 | 16.043 | 3.074 | 2.396 | 0 | 0.048 | 2.763 | 0.001 | 0.829 | 0.739 | 0.712 | 1.918 | 2.359 | 0.596 | 1.275 | 0.091 | 0.275 | 0 | 0.053 |
| Kosten van de omzet
| 1.068 | 0.882 | 0.84 | 0.622 | 0.547 | 0.131 | 0.081 | 4.672 | 0.122 | 3.578 | 3.619 | 3.267 | 0 | 0 | 0 | 0 | 0 | 0.272 | 0.137 | 0 |
| Brutowinst
| 20.992 | 14.924 | 15.203 | 2.452 | 1.849 | -0.131 | -0.033 | -1.909 | -0.121 | -2.749 | -2.88 | -2.555 | 1.918 | 2.359 | 0.596 | 1.275 | 0.091 | 0.003 | -0.137 | 0.053 |
| Brutowinstmarge
| 0.952 | 0.944 | 0.948 | 0.798 | 0.772 | 0 | -0.678 | -0.691 | -112.49 | -3.316 | -3.895 | -3.589 | 1 | 1 | 1 | 1 | 1 | 0.01 | 0 | 1 |
| Onderzoek- en ontwikkelingskosten
| 56.408 | 35.146 | 24.031 | 14.004 | 5.878 | 4.513 | 6.963 | 4.672 | 4.855 | 4.115 | 4.177 | 4.042 | 0 | 0 | 0 | 0 | 2.284 | 0 | 1.376 | 0.408 |
| Algemene en administratieve kosten
| 4.508 | 4.091 | 6.298 | 7.829 | 3.818 | 1.828 | 1.163 | 1.038 | 0.904 | 0.541 | 0.434 | 1.55 | 1.388 | 1.528 | 1.363 | 1.347 | 2.023 | 1.91 | 1.587 | 1.258 |
| Verkoop- en marketingkosten
| 0 | -0.956 | -0.96 | -0.622 | -0.541 | 1.818 | 1.421 | 0.814 | 1.108 | 1.314 | 1.368 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 |
| Verkoop-, algemene en administratieve kosten
| 4.508 | 3.135 | 5.338 | 7.207 | 3.277 | 2.458 | 2.724 | 1.852 | 0.974 | 1.856 | 1.802 | 1.55 | 1.388 | 1.528 | 1.363 | 1.347 | 2.023 | 1.91 | 1.587 | 1.258 |
| Overige kosten
| 0 | 15.752 | 15.922 | 3.133 | 0.063 | 0 | 0.048 | 2.763 | 0.001 | 0.066 | 0.047 | 0.712 | 4.596 | 4.548 | 3.897 | 3.63 | 0.784 | 0.605 | 0.034 | 0.127 |
| Bedrijfskosten
| 60.917 | 38.281 | 29.368 | 21.21 | 9.155 | 6.972 | 9.687 | 2.342 | 5.829 | 2.284 | 2.256 | 6.105 | 5.984 | 6.076 | 5.261 | 4.978 | 5.665 | 4.699 | 3.94 | 1.793 |
| Bedrijfsresultaat
| -38.857 | -39.163 | -30.208 | -21.833 | -9.702 | -7.102 | -9.768 | -4.252 | -5.951 | -5.033 | -5.136 | -6.105 | -4.066 | -3.718 | -4.664 | -3.703 | -5.574 | -4.696 | -4.077 | -1.741 |
| Bedrijfsresultaat ratio
| -1.761 | -2.478 | -1.883 | -7.102 | -4.05 | 0 | -201.571 | -1.539 | -5,530.651 | -6.071 | -6.946 | -8.575 | -2.12 | -1.576 | -7.823 | -2.904 | -61.418 | -17.052 | 0 | -33.125 |
| Totaal overige inkomsten en kosten netto
| 0.747 | 0 | -0.059 | 0.132 | 0.227 | 0.118 | 0.163 | 0.076 | -0.095 | 0.075 | 0.086 | 0.712 | 0.162 | 0.113 | 0.092 | -0.893 | 0.784 | 0.605 | -0.433 | 0.154 |
| Inkomen voor belasting
| -38.11 | -39.163 | -30.267 | -21.701 | -9.475 | -6.984 | -9.605 | -4.176 | -6.046 | -4.958 | -5.05 | -5.319 | -3.905 | -3.605 | -4.573 | -4.491 | -4.484 | -3.889 | -4.277 | -1.587 |
| Inkomen voor belasting ratio
| -1.728 | -2.478 | -1.887 | -7.059 | -3.955 | 0 | -198.201 | -1.511 | -5,618.885 | -5.98 | -6.829 | -7.471 | -2.035 | -1.529 | -7.669 | -3.522 | -49.409 | -14.121 | 0 | -30.203 |
| Belastingkosten
| -17.559 | -15.806 | -15.973 | -3.071 | -2.396 | -2.904 | -2.171 | 2.225 | -2.067 | 1.966 | 1.792 | -1.879 | 0 | 0 | 0 | 0.788 | -0.306 | -0.202 | -0.286 | -1.587 |
| Nettowinst
| -37.725 | -22.789 | -13.863 | -17.768 | -6.822 | -4.08 | -7.434 | -1.951 | -3.979 | -2.991 | -3.258 | -3.44 | -3.905 | -3.605 | -4.573 | -4.491 | -4.484 | -3.889 | -3.991 | -1.587 |
| Nettowinstmarge
| -1.71 | -1.442 | -0.864 | -5.779 | -2.848 | 0 | -153.405 | -0.706 | -3,697.651 | -3.608 | -4.406 | -4.832 | -2.035 | -1.529 | -7.669 | -3.522 | -49.409 | -14.121 | 0 | -30.203 |
| WPA (Winst Per Aandeel)
| -0.01 | -0.007 | -0.004 | -0.006 | -0.002 | -0.002 | -0.003 | -0.001 | -0.002 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.002 | -0.002 | -0.002 | -0.001 | -0.001 | -0.001 |
| Verwaterde WPA
| -0.01 | -0.007 | -0.004 | -0.006 | -0.002 | -0.002 | -0.003 | -0.001 | -0.002 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.002 | -0.002 | -0.002 | -0.001 | -0.001 | -0.001 |
| EBITDA
| -38.118 | -38.281 | -29.368 | -21.21 | -9.155 | -6.972 | -9.687 | -4.196 | -5.829 | -4.821 | -4.922 | -5.83 | -3.87 | -3.563 | -4.598 | -2.696 | -5.524 | -4.669 | -3.592 | -1.699 |
| EBITDA ratio
| -1.728 | -2.422 | -1.831 | -6.899 | -3.821 | 0 | -199.894 | -1.519 | -5,417.156 | -5.815 | -6.657 | -8.19 | -2.017 | -1.511 | -7.711 | -2.114 | -60.873 | -16.956 | 0 | -32.32 |